Cargando…

Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size

BACKGROUND: We investigated the correlation between cavity formation, prognosis, and tumor stage for pathologic stage I invasive lung adenocarcinomas (IADCs) ≤3 cm in size. MATERIAL/METHODS: 2106 candidates with pathologic stage I IADC were identified from Shanghai Chest Hospital between 2009 and 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chunji, Fu, Shijie, Ni, Qiming, Yiyang, Wang, Pan, Xufeng, Jiao, Jing, Zhao, Heng, Rui, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898982/
https://www.ncbi.nlm.nih.gov/pubmed/31772147
http://dx.doi.org/10.12659/MSM.917933
_version_ 1783477070175666176
author Chen, Chunji
Fu, Shijie
Ni, Qiming
Yiyang, Wang
Pan, Xufeng
Jiao, Jing
Zhao, Heng
Rui, Wang
author_facet Chen, Chunji
Fu, Shijie
Ni, Qiming
Yiyang, Wang
Pan, Xufeng
Jiao, Jing
Zhao, Heng
Rui, Wang
author_sort Chen, Chunji
collection PubMed
description BACKGROUND: We investigated the correlation between cavity formation, prognosis, and tumor stage for pathologic stage I invasive lung adenocarcinomas (IADCs) ≤3 cm in size. MATERIAL/METHODS: 2106 candidates with pathologic stage I IADC were identified from Shanghai Chest Hospital between 2009 and 2014. There were 227 patients who were diagnosed as having cavity formation and another 1879 patients who were not (the non-cavitary lung cancer group). Kaplan-Meier analysis curves were conducted to compare the overall survival (OS) and relapse-free survival (RFS) between these 2 groups. Cox proportional hazards regression was performed to discover the independent risk factors of OS and RFS. Receiver operating characteristic (ROC) curve was done to determine the cutoff value of cavity size for predicting prognosis. Furthermore, subgroup analysis was stratified by the size of tumor and the 8(th) classification of T category. RESULTS: Compared with non-cavitary lung cancer group, patients with cavity formation were found to have a higher prevalence of male patients (P=0.015), older age patients (P=0.039), larger size tumors (P=0.004), and worse cancer relapse (P<0.001). Survival analysis found that patients with cavitary IADC had significantly shorter RFS than those with non-cavitary IADC (P=0.001). Further, subgroup analysis confirmed a significantly worse RFS in cavitary IADC group both in stage T1a (P=0.002) and T1b (P<0.001), but not for stage T1c (P=0.962) and T2a (P=0.364). Moreover, cavity formation was still less of a significant predictor of RFS in multivariable analysis (hazard ratio [HR] 1.810, 95% confidence level [CI] 1.229–2.665, P=0.003). The ROC curve showed that the best cutoff value of maximum diameter of the cavity for judging RFS was 5 mm (sensitivity: 0.500; specificity: 0.783). At the same time, multiple cavities were more likely to lead to recurrence (sensitivity: 0.605; specificity: 0.439). CONCLUSIONS: Cavitary adenocarcinoma was a worse prognostic indicator compared with non-cavitary adenocarcinoma, especially for cavity >5 mm and multiple cavities. Thus, for stage T1a and T1b, cavitary and non-cavitary IADC should be considered separately.
format Online
Article
Text
id pubmed-6898982
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68989822019-12-16 Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size Chen, Chunji Fu, Shijie Ni, Qiming Yiyang, Wang Pan, Xufeng Jiao, Jing Zhao, Heng Rui, Wang Med Sci Monit Clinical Research BACKGROUND: We investigated the correlation between cavity formation, prognosis, and tumor stage for pathologic stage I invasive lung adenocarcinomas (IADCs) ≤3 cm in size. MATERIAL/METHODS: 2106 candidates with pathologic stage I IADC were identified from Shanghai Chest Hospital between 2009 and 2014. There were 227 patients who were diagnosed as having cavity formation and another 1879 patients who were not (the non-cavitary lung cancer group). Kaplan-Meier analysis curves were conducted to compare the overall survival (OS) and relapse-free survival (RFS) between these 2 groups. Cox proportional hazards regression was performed to discover the independent risk factors of OS and RFS. Receiver operating characteristic (ROC) curve was done to determine the cutoff value of cavity size for predicting prognosis. Furthermore, subgroup analysis was stratified by the size of tumor and the 8(th) classification of T category. RESULTS: Compared with non-cavitary lung cancer group, patients with cavity formation were found to have a higher prevalence of male patients (P=0.015), older age patients (P=0.039), larger size tumors (P=0.004), and worse cancer relapse (P<0.001). Survival analysis found that patients with cavitary IADC had significantly shorter RFS than those with non-cavitary IADC (P=0.001). Further, subgroup analysis confirmed a significantly worse RFS in cavitary IADC group both in stage T1a (P=0.002) and T1b (P<0.001), but not for stage T1c (P=0.962) and T2a (P=0.364). Moreover, cavity formation was still less of a significant predictor of RFS in multivariable analysis (hazard ratio [HR] 1.810, 95% confidence level [CI] 1.229–2.665, P=0.003). The ROC curve showed that the best cutoff value of maximum diameter of the cavity for judging RFS was 5 mm (sensitivity: 0.500; specificity: 0.783). At the same time, multiple cavities were more likely to lead to recurrence (sensitivity: 0.605; specificity: 0.439). CONCLUSIONS: Cavitary adenocarcinoma was a worse prognostic indicator compared with non-cavitary adenocarcinoma, especially for cavity >5 mm and multiple cavities. Thus, for stage T1a and T1b, cavitary and non-cavitary IADC should be considered separately. International Scientific Literature, Inc. 2019-11-27 /pmc/articles/PMC6898982/ /pubmed/31772147 http://dx.doi.org/10.12659/MSM.917933 Text en © Med Sci Monit, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Chen, Chunji
Fu, Shijie
Ni, Qiming
Yiyang, Wang
Pan, Xufeng
Jiao, Jing
Zhao, Heng
Rui, Wang
Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size
title Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size
title_full Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size
title_fullStr Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size
title_full_unstemmed Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size
title_short Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size
title_sort cavity formation is a prognostic indicator for pathologic stage i invasive lung adenocarcinoma of ≥3 cm in size
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898982/
https://www.ncbi.nlm.nih.gov/pubmed/31772147
http://dx.doi.org/10.12659/MSM.917933
work_keys_str_mv AT chenchunji cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize
AT fushijie cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize
AT niqiming cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize
AT yiyangwang cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize
AT panxufeng cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize
AT jiaojing cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize
AT zhaoheng cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize
AT ruiwang cavityformationisaprognosticindicatorforpathologicstageiinvasivelungadenocarcinomaof3cminsize